[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352507-105":59,"doc-detail-352507-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","overexpression-and-prognostic-value-of-aspartate-hydroxylase-in-lung-adenocarcinoma-a-comprehensive-study-based-on-bioinformatics-and-clinical-tissue-sample-validation","Overexpression and prognostic value of aspartate β-hydroxylase in lung adenocarcinoma - a comprehensive study based on bioinformatics and clinical tissue sample validation","","Lung adenocarcinoma (LUAD) remains a major cause of cancer mortality, yet clinically used biomarkers show limited value for robust prognostic stratification. This study integrates pan-cancer and LUAD analyses of ASPH mRNA using TIMER and TCGA with protein validation by immunohistochemistry in 120 LUAD tissue specimens. Survival modeling (Kaplan-Meier and Cox regression) links ASPH to overall and progression-free survival, while GSEA and co-expression analyses probe underlying molecular mechanisms.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/overexpression-and-prognostic-value-of-aspartate-hydroxylase-in-lung-adenocarcinoma-a-comprehensive-study-based-on-bioinformatics-and-clinical-tissue-sample-validation/352507/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/overexpression-and-prognostic-value-of-aspartate-hydroxylase-in-lung-adenocarcinoma-a-comprehensive-study-based-on-bioinformatics-and-clinical-tissue-sample-validation/352507.png","ImageObject",300,407,{"name":92,"@type":93},"River Wang","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How was ASPH expression analyzed in this study?","Question",{"text":112,"@type":113},"ASPH mRNA expression was assessed across pan-cancers and in LUAD using TIMER and TCGA. ASPH protein expression was then validated by immunohistochemical staining in 120 clinical LUAD specimens.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What relationship was found between ASPH expression and patient outcomes?",{"text":117,"@type":113},"Higher ASPH expression was associated with poorer overall survival (OS) and progression-free survival (PFS). Multivariate Cox regression further supported ASPH as an independent prognostic factor for OS and PFS in the study cohorts.",{"name":119,"@type":110,"acceptedAnswer":120},"Which downstream mechanisms and pathway links were explored for ASPH?",{"text":121,"@type":113},"Gene Set Enrichment Analysis (GSEA) and Pearson co-expression analyses were used to explore mechanisms, including co-expression with oncogenes such as RGS20 and MET and enrichment in pathways related to cell proliferation, immune regulation, and cell adhesion.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},352507,1790158913,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","Zheng et al. World Journal of Surgical Oncology (2026) 24:102  \n[https://doi.org/10.1186/s12957-026-04234-5](https://doi.org/10.1186/s12957-026-04234-5)  \nWorld Journal of Surgical Oncology  \nRESEARCH Open Access  \nOverexpression and prognostic value of aspartate β-hydroxylase in lung adenocarcinoma: a comprehensive study based on bioinformatics and clinical tissue sample validation  \nQingzhu Zheng1,2†, Jiamiao Weng2,3†, Bin Zhu1,2, Mingjie Li1,2, Xianjin Zhu1,2* and Yingping Cao1,2*  \nAbstract  \nBackground Lung adenocarcinoma (LUAD) is a leading cause of cancer-related mortality worldwide. Although established biomarkers guide targeted therapy, their utility in prognostic stratification remains limited. In this study, we.  \nMethods ASPH mRNA expression across pan-cancers and in LUAD was analyzed using the TIMER and The Cancer Genome Atlas (TCGA) databases. Immunohistochemical (IHC) staining was performed on 120 clinical LUAD specimens to validate ASPH protein expression. Kaplan-Meier survival analysis was used to assess the association between ASPH expression and overall survival (OS) as well as progression-free survival (PFS) . Univariate and multivariate Cox proportional hazards regression models were applied to evaluate the prognostic value of ASPH. Gene Set Enrichment Analysis (GSEA) and Pearson co-expression analysis were conducted to explore potential molecular mechanisms.  \nResults ASPH was significantly upregulated in LUAD tissues at both mRNA and protein levels compared with corresponding normal lung tissues (all p \u003C 0 . 001) . High ASPH expression was closely correlated with aggressive clinicopathological features, including larger tumor size, T-stage parameters, lymph node/distant metastasis, and advanced clinical stage (all p \u003C 0. 05) . Kaplan-Meier analysis showed that high ASPH expression was associated with poorer OS and PFS (both p \u003C 0. 001) . Multivariate Cox regression confirmed ASPH as an independent prognostic factor for OS (TCGA cohort: HR = 1. 01, 95% CI = 1.00–1. 01, p = 0 . 003; clinical cohort: HR = 1. 85, 95% CI = 1.03–3. 30, p = 0 . 04) and PFS (clinical cohort: HR = 1. 84, 95% CI = 1.08–3. 14, p = 0 . 03) . Co-expression analysis revealed ASPH was positively correlated with oncogenes RGS20 (r = 0 . 547) and MET (r = 0 . 516) . GSEA indicated ASPH-coexpressed genes  \n†Qingzhu Zheng and Jiamiao Weng contributed equally to this work.  \n*Correspondence:  \nXianjin Zhu [zxj5027667@163.com](zxj5027667@163.com)[ ](zxj5027667@163.com)Yingping Cao [caoyingping@aliyun.com](caoyingping@aliyun.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nZheng et al. World Journal of Surgical Oncology (2026) 24:102 Page 2 of 13  \nwere enriched in pathways related to cell proliferation (ribosome, DNA replication, cell cycle), immune regulation (granulocyte activation, ne","cbCaivQzxBAzzgMJ","https://ap.wps.com/l/cbCaivQzxBAzzgMJ","pdf",5607999,13,"English","# Abstract\n# Background\n# Methods\n# Results\n# Conclusion\n# Introduction","[{\"question\":\"How was ASPH expression analyzed in this study?\",\"answer\":\"ASPH mRNA expression was assessed across pan-cancers and in LUAD using TIMER and TCGA. ASPH protein expression was then validated by immunohistochemical staining in 120 clinical LUAD specimens.\"},{\"question\":\"What relationship was found between ASPH expression and patient outcomes?\",\"answer\":\"Higher ASPH expression was associated with poorer overall survival (OS) and progression-free survival (PFS). Multivariate Cox regression further supported ASPH as an independent prognostic factor for OS and PFS in the study cohorts.\"},{\"question\":\"Which downstream mechanisms and pathway links were explored for ASPH?\",\"answer\":\"Gene Set Enrichment Analysis (GSEA) and Pearson co-expression analyses were used to explore mechanisms, including co-expression with oncogenes such as RGS20 and MET and enrichment in pathways related to cell proliferation, immune regulation, and cell adhesion.\"}]","Overexpression and prognostic value of aspartate β-hydroxylase in lung adenocarcinoma - a comprehensive study based on bioinformatics and clinical tissue sample validation | PDF",1790100039,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a9e27f266ed687501f8f8470108bac91.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/733af562e71b5cec953afa347ef3356f.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/da9ebf31a3805e9d3e29e6d4b54a557c.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8187937646e79498019e8ac16f7d9744.webp",980,1306]